![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hg2376contents.gif)
Acta Cryst. (2008). E64, o639 [ doi:10.1107/S1600536808003322 ]
Abstract: The title compound [systematic name: (12R)-4,8-dimethyl-12-[(1'R)-1',2',3',4'-tetrahydro-1'-naphthyl)aminomethyl]-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one}, C25H33NO3, was formed from the reaction of (1R)-1-aminotetralin with parthenolide in methanolic solution. X-ray crystal structure analysis determined that the configuration of the new chiral center in the title compound was R.
Online 29 February 2008
Copyright © International Union of Crystallography
IUCr Webmaster